After attending the course, participants will understand the molecular targeting approach to the treatment of cancer; become familiar with new therapeutic radiopharmaceuticals and their clinical results to date; and learn about current and future directions of research.
Nuclear Oncology: From Genotype to Phenotype to Targeted Therapy
Mar 13th, 2008Mar 14th, 2008
Baltimore, MD
US
Latest in Home
New benchmark helps monitor cumulative CT radiation dose
February 13, 2026
Study questions routine use of radiotherapy after bone surgery
February 13, 2026












